Just In
HCL FY26 Guidance: Revenue growth expected to be between 3.0%-5.0% YoY in CC
HCL reported revenue of $3,545 million in USD terms, marking a 1.3% increase QoQ and 5.4% growth YoY
HCL's revenue in constant currency declined 0.8% quarter-on-quarter but grew 3.7% year-on-year
HCL FY26 Guidance: Revenue growth expected to be between 3.0%-5.0% YoY in CC
HCL reported revenue of $3,545 million in USD terms, marking a 1.3% increase QoQ and 5.4% growth YoY
HCL's revenue in constant currency declined 0.8% quarter-on-quarter but grew 3.7% year-on-year

Serum Institute of India

(30 search results)

Poonawalla Reaps Riches In Vaccine Rollouts
Pharma's Richest Ride Demand Tailwinds
Serum Institute to double its investment in Biocon subsidiary to $300 mn
Covid catapults Cyrus Poonawalla to richest in pharma
Poonawalla, The Mass Saviour

Poonawalla, The Mass Saviour

Serum to launch India's first indigenous cervical cancer vaccine
Serum not making fresh vaccines amid surplus stock: Poonawalla
Serum's Poonawalla pitches for global pandemic treaty for free flow of vaccines
Covid-19: 2 new vaccines, 1 drug join fight against virus in India
Common global rules must for new Covid drug trials: Adar Poonawalla